News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
403,377 Results
Type
Article (23703)
Company Profile (164)
Press Release (379510)
Section
Business (131065)
Career Advice (986)
Deals (21290)
Drug Delivery (96)
Drug Development (58959)
Employer Resources (91)
FDA (9011)
Job Trends (9661)
News (223376)
Policy (20057)
Tag
Academia (1540)
Alliances (40714)
Alzheimer's disease (760)
Approvals (8976)
Artificial intelligence (115)
Bankruptcy (190)
Best Places to Work (7299)
Biosimilars (68)
Biotechnology (80)
Breast cancer (78)
Cancer (763)
Cardiovascular disease (70)
Career advice (810)
Cell therapy (140)
Clinical research (47793)
Collaboration (405)
Compensation (83)
COVID-19 (1414)
C-suite (76)
Data (788)
Diabetes (110)
Diagnostics (2963)
Drug pricing (91)
Earnings (45024)
Employer resources (83)
Events (58304)
Executive appointments (232)
FDA (9359)
Funding (214)
Gene therapy (115)
GLP-1 (524)
Government (2481)
Healthcare (8986)
Infectious disease (1477)
Inflammatory bowel disease (80)
Interviews (134)
IPO (8860)
Job creations (2656)
Job search strategy (731)
Layoffs (297)
Legal (4384)
Lung cancer (129)
Manufacturing (153)
Medical device (3966)
Medtech (3971)
Mergers & acquisitions (12494)
Metabolic disorders (348)
Neuroscience (958)
NextGen Class of 2024 (3313)
Non-profit (2264)
Northern California (891)
Obesity (217)
Opinion (182)
Patents (75)
People (37320)
Pharmaceutical (79)
Phase I (15192)
Phase II (20604)
Phase III (15948)
Pipeline (357)
Policy (74)
Postmarket research (1741)
Preclinical (5809)
Radiopharmaceuticals (184)
Rare diseases (173)
Real estate (3880)
Regulatory (14041)
Research institute (1432)
Resumes & cover letters (157)
Southern California (791)
Startups (2344)
United States (8034)
Vaccines (293)
Weight loss (184)
Date
Today (59)
Last 7 days (443)
Last 30 days (2378)
Last 365 days (23093)
2024 (21107)
2023 (25398)
2022 (32642)
2021 (34406)
2020 (32847)
2019 (27055)
2018 (20392)
2017 (21290)
2016 (20266)
2015 (22944)
2014 (17640)
2013 (14661)
2012 (15628)
2011 (16073)
2010 (14640)
Location
Africa (479)
Arizona (66)
Asia (29054)
Australia (3913)
California (1985)
Canada (857)
China (184)
Colorado (111)
Connecticut (110)
Europe (61101)
Florida (271)
Illinois (197)
Indiana (132)
Maryland (324)
Massachusetts (1627)
Minnesota (111)
New Jersey (684)
New York (601)
North Carolina (458)
Northern California (891)
Ohio (86)
Pennsylvania (490)
South America (712)
Southern California (791)
Texas (271)
Washington State (182)
403,377 Results for "collaborations pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
Nxera Pharma Co. Ltd, announces that it has reached an important R&D milestone under its multi-target discovery collaboration with AbbVie targeting neurological diseases, resulting in a payment of US$10 million to Nxera.
June 26, 2024
·
3 min read
Business
Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
Nascent Biotech, Inc. and HypoSpray Pharma announced today a collaboration to develop an alternative delivery mechanism for patients who can benefit from Pritumumab.
March 19, 2024
·
4 min read
Press Releases
Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
November 5, 2024
·
4 min read
Press Releases
Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases
November 5, 2024
·
6 min read
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Business
Vivtex Enters Research Collaboration with Astellas Pharma
Vivtex Corporation announces that it has entered a research collaboration with Astellas Pharma Inc. (“Astellas”), a global pharmaceutical company.
January 23, 2024
·
2 min read
Business
Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration
Silence Therapeutics plc today announced that it will receive a $2.0 million cash payment from Hansoh Pharmaceutical Group Company Limited (“Hansoh”) following the achievement of a second undisclosed milestone related to the first target under the collaboration.
June 24, 2024
·
5 min read
1 of 40,338
Next
